eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-STOK-Stoke Therapeutics Inc

Stoke Therapeutics Inc STOK

‎$‎32.361.38(4.46%)(1D)
• Delayed prices by NASDAQ • in USD
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Price Target
41.17
Based on analysts who covered STOK
Invest in Stoke Therapeutics Inc
Today
Create an eToro account to buy STOK stock on a secure, user-friendly, multi-asset trading platform.
Buy Stoke Therapeutics Inc
Stoke Therapeutics Inc STOK
Buy STOK

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Stoke Therapeutics Inc News

STOK Stock Price Chart

‎17.08‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset stable trend

The Stoke Therapeutics Inc share price is stable this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Stoke Therapeutics Inc share price today is ‎$‎32.36, reflecting a ‎4.46‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of STOK is ‎$‎1.77B with an average volume in the last three months of 781269.69. The stock has a P/E ratio of 46.95 and a dividend yield of 0%. With the stock’s beta sitting at 1.31
Why invest in stocks on eToro?
Start with ‎$‎50

Start with ‎$‎50

Low fees

Low fees

users worldwide

users worldwide

Across 70+ countries

Across 70+ countries

BackgroundPhone
Get Started
BackgroundPhone
STOK Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎1.77B
Day’s Range
i
Shows the high and low prices of the day.
‎$‎30.45 - ‎$‎33.37
52W Range
i
Shows the high and low prices of the last year.
‎$‎5.43 - ‎$‎38.5
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
781269.69
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
46.95
Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎205.63M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎30.98
EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎0.66
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.31

How can I buy Stoke Therapeutics Inc stocks?

To purchase Stoke Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Stoke Therapeutics Inc (STOK) page and place an order to buy Stoke Therapeutics Inc.
Buy STOK
Looking for more information? Check out our guide on Academy.
What Is Stoke Therapeutics Inc?
Stoke Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing RNA-based therapies for the treatment of severe genetic diseases. Operating principally in the US, Stoke Therapeutics’ goal is to enhance quality of life for patients and their families.

Operating in the biopharmaceutical sector, Stoke Therapeutics is developing a pipeline of antisense oligonucleotides (ASO)-based therapies. The company’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) platform allows it to develop ASOs that selectively restore protein levels.

Track the share price of STOK by adding it to your eToro watchlist.
CEO
Ian Frederick Smith, CPA
Employees
128
Founded
2014
HQ
Bedford, Massachusetts, US
Med Tech
NASDAQ
Get Started
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2026
Top Dividend Stocks for 2026
Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.
Read More
AI Stocks Poised for Growth in 2026
AI Stocks Poised for Growth in 2026
Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Stoke Therapeutics Inc
Invest in Stoke Therapeutics Inc
Today
Create an eToro account to buy STOK stock on a secure, user-friendly, multi-asset trading platform.
Get Started

FAQ

The current price of STOK is ‎$‎32.36.
The average price target for Stoke Therapeutics Inc is ‎$‎41.17. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Stoke Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Stoke Therapeutics Inc is ‎$‎1.77B
Based on 6 analysts offering recommendations for STOK in the last 3 months, the overall consensus is .
Daily Movers
Explore the biggest stocks movers on the market.
Buy STOK
English (UK)English (UK)Check icon
DeutschDeutsch
FrançaisFrançais
PolskiPolski
PortuguêsPortuguês
DanskDansk
SuomiSuomi
EspañolEspañol
РусскийРусский
العربيةالعربية
NederlandsNederlands
SvenskaSvenska
RomânăRomână
ItalianoItaliano
中文中文
繁體中文繁體中文
NorskNorsk
ČeštinaČeština
Tiếng ViệtTiếng Việt
ΕλληνικάΕλληνικά
Scroll to top